IMC Chicago
NVO

IMC Chicago’s Novo Nordisk NVO Stock Holding History

IMC Chicago’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$72.8M Sell
1,518,300
-336,100
-18% -$14.4M 0.02% 458
2026
Q1 		$68.1M Buy
1,854,400
+385,700
+26% +$18.3M 0.02% 403
2025
Q4 		$74.7M Sell
1,468,700
-1,420,700
-49% -$72.6M 0.03% 367
2025
Q3 		$160M Buy
2,889,400
+1,891,600
+190% +$111M 0.06% 185
2025
Q2 		$68.9M Buy
997,800
+178,700
+22% +$12.2M 0.03% 316
2025
Q1 		$56.9M Buy
819,100
+206,300
+34% +$17M 0.03% 291
2024
Q4 		$52.7M Buy
612,800
+73,400
+14% +$7.94M 0.02% 329
2024
Q3 		$64.2M Buy
539,400
+52,000
+11% +$6.93M 0.03% 253
2024
Q2 		$69.6M Buy
487,400
+38,700
+9% +$5.13M 0.04% 222
2024
Q1 		$57.6M Buy
448,700
+181,600
+68% +$21.6M 0.04% 222
2023
Q4 		$27.6M Buy
267,100
+149,100
+126% +$14.7M 0.02% 380
2023
Q3 		$10.7M Buy
+118,000
New +$10.4M 0.01% 541

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

IMC Chicago's NVO Position: Q2 2026 in Review

IMC Chicago sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 802,198 shares — an estimated $34.5M sold.

IMC Chicago first reported a position in NVO in Q3 2024 and held it in 7 quarters. The position peaked at $29.5M in Q1 2026. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • IMC Chicago reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • IMC Chicago sold 802,198 Novo Nordisk shares in Q2 2026, an estimated $34.5M.
  • IMC Chicago first reported a position in Novo Nordisk in Q3 2024 and held it in 7 quarters.
  • IMC Chicago's Novo Nordisk position peaked at $29.5M in Q1 2026.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.